Integer Holdings Corp (ITGR)
109.58
-1.57
(-1.41%)
USD |
NYSE |
Apr 26, 16:00
109.60
+0.02
(+0.02%)
After-Hours: 20:00
Integer Holdings Research and Development Expense (Quarterly): 15.75M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 15.75M |
| December 31, 2023 | 13.26M |
| September 30, 2023 | 14.54M |
| June 30, 2023 | 16.88M |
| March 31, 2023 | 19.09M |
| December 31, 2022 | 13.84M |
| September 30, 2022 | 16.12M |
| June 30, 2022 | 14.87M |
| March 31, 2022 | 16.08M |
| December 31, 2021 | 12.74M |
| September 30, 2021 | 12.05M |
| June 30, 2021 | 13.74M |
| March 31, 2021 | 13.46M |
| December 31, 2020 | 10.59M |
| September 30, 2020 | 11.89M |
| June 30, 2020 | 12.75M |
| March 31, 2020 | 13.24M |
| December 31, 2019 | 11.81M |
| September 30, 2019 | 11.73M |
| June 30, 2019 | 11.40M |
| March 31, 2019 | 11.60M |
| December 31, 2018 | 10.16M |
| September 30, 2018 | 12.23M |
| June 30, 2018 | 12.94M |
| March 31, 2018 | 13.28M |
| Date | Value |
|---|---|
| December 31, 2017 | 13.75M |
| September 30, 2017 | 12.23M |
| June 30, 2017 | 11.24M |
| March 31, 2017 | 13.41M |
| December 31, 2016 | 5.541M |
| September 30, 2016 | 11.41M |
| June 30, 2016 | 13.64M |
| March 31, 2016 | 17.31M |
| December 31, 2015 | 13.09M |
| September 30, 2015 | 14.30M |
| June 30, 2015 | 13.06M |
| March 31, 2015 | 12.54M |
| December 31, 2014 | 9.883M |
| September 30, 2014 | 13.64M |
| June 30, 2014 | 12.79M |
| March 31, 2014 | 13.53M |
| December 31, 2013 | 15.09M |
| September 30, 2013 | 13.81M |
| June 30, 2013 | 14.10M |
| March 31, 2013 | 11.08M |
| December 31, 2012 | 11.16M |
| September 30, 2012 | 13.24M |
| June 30, 2012 | 14.17M |
| March 31, 2012 | 13.91M |
| December 31, 2011 | 12.80M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
10.59M
Minimum
Dec 2020
19.09M
Maximum
Mar 2023
13.79M
Average
13.36M
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 366.00M |
| Masimo Corp | 38.00M |
| ResMed Inc | 73.88M |
| Accuray Inc | 15.28M |
| Merit Medical Systems Inc | 21.64M |